AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2014
Jan 31, 2014
29745_dirs_2014-01-30_db450b39-2fb6-4bca-88ba-d97fec63878b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-01-28
Reporting Person: Rice Derica W (EVP-Global Services and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-28 | Common Stock | A | 59575 | $54.23 | Acquired | 59575 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-28 | Restricted Stock Unit | $ | A | 26581 | Acquired | 2015-02-01 | Common Stock (26581.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6762 | Indirect |
| Common Stock | 217524 | Indirect |
| Common Stock | 1758 | Indirect |
Footnotes
F1: Reporting person disclaims beneficial ownership of these shares.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29